Detalles de la búsqueda
1.
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(4): 387-405, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390769
2.
Challenges associated with the integration of immuno-oncology agents in clinical practice.
BMC Med Educ
; 22(1): 781, 2022 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371179
3.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
J Natl Compr Canc Netw
; 18(3): 230-241, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135517
4.
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 17(5.5): 574-578, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31117034
5.
Management of Immunotherapy-Related Toxicities, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 255-289, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865922
6.
The prevalence and related factors associated with psychosocial distress among 420 hospitalised lung cancer patients in China: A case study.
Eur J Cancer Care (Engl)
; 28(4): e13046, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31016811
7.
Every story has two sides: evaluating information processing and ecological dynamics perspectives of focus of attention in skill acquisition.
Front Sports Act Living
; 5: 1176635, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293436
8.
Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse.
Clin J Oncol Nurs
; 26(3): 245-251, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35604726
9.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
J Immunother Cancer
; 10(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640927
10.
Impact of an Animation Education Program on Promoting Compliance With Active Respiratory Rehabilitation in Postsurgical Lung Cancer Patients: A Randomized Clinical Trial.
Cancer Nurs
; 44(2): 106-115, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-31714266
11.
Learning and Expertise in Mineral Exploration Decision-Making: An Ecological Dynamics Perspective.
Int J Environ Res Public Health
; 18(18)2021 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34574692
12.
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
J Clin Oncol
; 39(35): 3978-3992, 2021 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724386
13.
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
J Clin Oncol
; 39(36): 4073-4126, 2021 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724392
14.
Evidence-Based Antiemetic Decision Tool for Management of Postoperative Nausea and Vomiting in Patients at High Risk of QT Prolongation and Patients Receiving Neurotransmitter-Modulating Medications.
AANA J
; 88(4): 312-318, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32718430
15.
Durvalumab Immunotherapy: Nursing Management of Immune-Related Adverse Events During the Journey of Patients With Stage III Non-Small Cell Lung Cancer.
Clin J Oncol Nurs
; 24(3): 277-283, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32441679
16.
Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer.
Cancer Treat Rev
; 85: 101979, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32078962
17.
Management of Pneumonitis and Neuropathy in Patients Receiving PD-1-Based Therapy for Non-Small-Cell Lung Cancer.
JCO Oncol Pract
; 16(2_suppl): 4s-9s, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045539
18.
Acute and Long-term Adverse Events Associated With Checkpoint Blockade.
Semin Oncol Nurs
; 35(5): 150926, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31514992
19.
PD-1/PD-L1 Inhibitors for Non-Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management.
J Adv Pract Oncol
; 10(Suppl 1): 21-35, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014515
20.
Research Agenda of the Oncology Nursing Society: 2019-2022.
Oncol Nurs Forum
; 46(6): 654-669, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31626621